D. E. Shaw & Co., Inc. Procept Bio Robotics Corp Call Options Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRCT
# of Institutions
173Shares Held
38.1MCall Options Held
386KPut Options Held
259K-
Cpmg Inc Dallas, TX5.33MShares$339 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.25MShares$270 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$209 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.94MShares$187 Million0.09% of portfolio
-
Alliancebernstein L.P. New York, NY1.99MShares$126 Million0.04% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.84B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...